ANA Investigates Advanced Therapies for Glioblastoma Ft. Dr. Eric Wong
“Glioblastoma is the most common malignant brain tumor and one of the most aggressive solid tumors. Much progress has been made in the understanding and classification of gliomas, but progress in terms of prolonging survival has been limited. Several recent investigational therapies are bringing new hope. Our guest today is Dr. Eric Wong from Brown University. He is an international expert on advanced treatments for glioblastoma and a Professor of Medicine, Radiation Oncology, Neurosurgery, and Neurology at Brown University. He was interviewed by Dr. Christoph Stretz, a Vascular and Critical Care neurologist at Brown. Series 5, Episode 6”
Eric T Wong, MD conducts clinical trials and serves on an advisory board sponsored by Novocure. Dr. Wong also serves on DSMB for Turning Point Therapeutics & Bristol Myers Squibb, and conducts clinical trials for AstraZeneca, Daiichi Sankyo, Imvax, MimiVax, Oblato, Ono Pharmaceuticals, Orbus, and Regeneron.
Featured